Aligos Therapeutics, Inc. · NASDAQ:ALGS
Armistice Capital, LLC's stake in Aligos Therapeutics, Inc. fell to 4.99% (Schedule 13G/A)
Event Dec 31, 2024 · Filed Feb 14, 2025
Armistice Capital, LLC's stake in Aligos Therapeutics, Inc. fell to 4.99%, 188,438 shares, as a passive investor on Dec 31, 2024. Filed Feb 14, 2025 (Schedule 13G/A).
- Stake
- 4.99%
- Shares
- 188,438
- Intent
- Passive
- What changed
- Fell below 5%
- Filed together
- 2 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| Armistice Capital, LLC | 4.99% | 188,438 |
| Steven Boyd | 4.99% | 188,438 |
Source
Related
- Aligos Therapeutics, Inc.
- Armistice Capital, LLC
- Aligos Therapeutics, Inc. shareholders
- Schedule 13D · Lawrence M. Blatt · Jun 24, 2026
- Schedule 13G/A · Woodline Partners LP · May 15, 2026
- Schedule 13G · Lawrence M. Blatt · May 15, 2026
- Schedule 13G/A · Woodline Partners LP · Feb 17, 2026
- Schedule 13G/A · Sio Capital Management, LLC · Feb 11, 2026